These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21732051)

  • 1. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis.
    Suwannalai P; Trouw LA; Toes RE; Huizinga TW
    Mod Rheumatol; 2012 Feb; 22(1):15-20. PubMed ID: 21732051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
    Hayashi N; Kumagai S
    Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System.
    Martin L; Steber WA; Lupton TL; Mahler M; Fitch CM; McMillan JD; Schmidt DR; Fritzler MJ
    J Rheumatol; 2015 May; 42(5):771-7. PubMed ID: 25641884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-citrullinated peptide antibodies is more than an accurate tool for diagnosis of rheumatoid arthritis.
    Goldman K; Gertel S; Amital H
    Isr Med Assoc J; 2013 Sep; 15(9):516-9. PubMed ID: 24340846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
    Luban S; Li ZG
    Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
    Farid SSh; Azizi G; Mirshafiey A
    Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
    Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
    Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CCP antibodies: the past, the present and the future.
    van Venrooij WJ; van Beers JJ; Pruijn GJ
    Nat Rev Rheumatol; 2011 Jun; 7(7):391-8. PubMed ID: 21647203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
    Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
    Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of rheumatoid arthritis: an introduction to the newly designed Iran Criteria for Rheumatoid Arthritis.
    Salehi I; Khazaeli S; Khak M
    Rheumatol Int; 2013 Jan; 33(1):45-50. PubMed ID: 22215043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
    Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
    Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons.
    Alivernini S; Galeazzi M; Peleg H; Tolusso B; Gremese E; Ferraccioli G; Naparstek Y
    Autoimmun Rev; 2017 Nov; 16(11):1096-1102. PubMed ID: 28899798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are rheumatoid arthritis patients discernible from other early arthritis patients using 1.5T extremity magnetic resonance imaging? a large cross-sectional study.
    Stomp W; Krabben A; van der Heijde D; Huizinga TW; Bloem JL; van der Helm-van Mil AH; Reijnierse M
    J Rheumatol; 2014 Aug; 41(8):1630-7. PubMed ID: 25028382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?
    Zhao J; Liu X; Wang Z; Liu R; Li Z
    J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Hensvold AH; Frisell T; Magnusson PK; Holmdahl R; Askling J; Catrina AI
    Ann Rheum Dis; 2017 Jan; 76(1):119-125. PubMed ID: 27125521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining anti-cyclic citrullinated peptide with the American College of Rheumatology 1987 criteria failed to improve early rheumatoid arthritis diagnosis in the community-based very early arthritis cohort.
    Le Loët X; Strotz V; Lequerré T; Boumier P; Pouplin S; Mejjad O; Daragon A; Jouen F; Vittecoq O; Fardellone P; Ménard JF
    Rheumatology (Oxford); 2011 Oct; 50(10):1901-7. PubMed ID: 21750000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.